111 related articles for article (PubMed ID: 9225333)
1. Catabolism of lipoprotein-X induced by infusion of 10% fat emulsion.
Abe M; Kawano M; Tashiro T; Yamamori H; Takagi K; Morishima Y; Shirai K; Saitou Y; Nakajima N
Nutrition; 1997 May; 13(5):417-21. PubMed ID: 9225333
[TBL] [Abstract][Full Text] [Related]
2. [Catabolism of lipoprotein-X (Lp-X) induced by infusion of 10% intralipid].
Abe M; Tashiro T; Mashima Y; Yamamori H; Nishizawa M; Sanada M; Okui K
Nihon Geka Gakkai Zasshi; 1991 Dec; 92(12):1678-85. PubMed ID: 1809875
[TBL] [Abstract][Full Text] [Related]
3. Increased lipoprotein X causes hyperlipidemia during intravenous administration of 10% fat emulsion in man.
Tashiro T; Mashima Y; Yamamori H; Horibe K; Nishizawa M; Sanada M; Okui K
JPEN J Parenter Enteral Nutr; 1991; 15(5):546-50. PubMed ID: 1942468
[TBL] [Abstract][Full Text] [Related]
4. Appearance and characterization of lipoprotein X during continuous intralipid infusions in the neonate.
Griffin E; Breckenridge WC; Kuksis A; Bryan MH; Angel A
J Clin Invest; 1979 Dec; 64(6):1703-12. PubMed ID: 227938
[TBL] [Abstract][Full Text] [Related]
5. Effects of intravenous infusions of commercial fat emulsions (Intralipid 10 or 20%) on rat plasma lipoproteins: phospholipids in excess are the main precursors of lipoprotein-X-like particles.
Hajri T; Férézou J; Lutton C
Biochim Biophys Acta; 1990 Nov; 1047(2):121-30. PubMed ID: 2248969
[TBL] [Abstract][Full Text] [Related]
6. Intravenous intralipid 10% vs. 20%, hyperlipidemia, and increase in lipoprotein X in humans.
Tashiro T; Mashima Y; Yamamori H; Sanada M; Nishizawa M; Okui K
Nutrition; 1992; 8(3):155-60. PubMed ID: 1525430
[TBL] [Abstract][Full Text] [Related]
7. Alteration of lipoprotein profile during total parenteral nutrition with intralipid 10%.
Tashiro T; Mashima Y; Yamamori H; Okui K
JPEN J Parenter Enteral Nutr; 1986; 10(6):622-6. PubMed ID: 3099006
[TBL] [Abstract][Full Text] [Related]
8. Intralipid infusion abolishes ability of human serum to cholesterol-load cultured macrophages.
Aviram M; Williams KJ; McIntosh RA; Carpentier YA; Tall AR; Deckelbaum RJ
Arteriosclerosis; 1989; 9(1):67-75. PubMed ID: 2912423
[TBL] [Abstract][Full Text] [Related]
9. Slow beta-migrating lipoprotein: an atherogenic subclass of low density lipoproteins.
Kawano M; Shinomiya M; Kanzaki T; Morisaki N; Shirai K; Saito Y; Yoshida S
Clin Biochem; 1996 Jun; 29(3):241-8. PubMed ID: 8740510
[TBL] [Abstract][Full Text] [Related]
10. Controversy over the atherogenicity of lipoprotein-X.
Miida T; Hirayama S
Curr Opin Endocrinol Diabetes Obes; 2019 Apr; 26(2):117-123. PubMed ID: 30694826
[TBL] [Abstract][Full Text] [Related]
11. Hyperlipidemia and atherosclerosis associated with liver disease in ferrochelatase-deficient mice.
Bloks VW; Plösch T; van Goor H; Roelofsen H; Baller J; Havinga R; Verkade HJ; van Tol A; Jansen PL; Kuipers F
J Lipid Res; 2001 Jan; 42(1):41-50. PubMed ID: 11160364
[TBL] [Abstract][Full Text] [Related]
12. Short-term effects of fat emulsion on serum lipids in postoperative patients.
Meguid MM; Kurzer M; Hayashi RJ; Akahoshi MP
JPEN J Parenter Enteral Nutr; 1989; 13(1):77-80. PubMed ID: 2494371
[TBL] [Abstract][Full Text] [Related]
13. Human plasma lipoproteins and total parenteral nutrition with intravenous fat emulsion.
Judd RH; Freund H; Deckelbaum RJ
JPEN J Parenter Enteral Nutr; 1984; 8(5):552-5. PubMed ID: 6436530
[TBL] [Abstract][Full Text] [Related]
14. Differential abilities of mouse liver parenchymal and nonparenchymal cells in HDL and LDL (native and oxidized) association and cholesterol efflux.
Lapointe J; Truong TQ; Falstrault L; Brissette L
Biochem Cell Biol; 2006 Apr; 84(2):250-6. PubMed ID: 16609706
[TBL] [Abstract][Full Text] [Related]
15. Reverse cholesterol transport in the rat following a short-term intravenous infusion of fat emulsion.
Wang WQ; Wang XD; Sun ZW; Hanson P; Gustafson A
Pharmacol Toxicol; 1996 Aug; 79(2):49-54. PubMed ID: 8878245
[TBL] [Abstract][Full Text] [Related]
16. Short-term parenteral nutrition with glucose and Intralipid: effects on serum lipids and lipoproteins.
Weinberg RB; Singh KK
Am J Clin Nutr; 1989 May; 49(5):794-8. PubMed ID: 2497630
[TBL] [Abstract][Full Text] [Related]
17. Interaction of various lipoproteins from normal and dyslipoproteinemic plasma with mouse peritoneal macrophages.
Rotheneder M; Krempler F; Kostner GM
Ann Biol Clin (Paris); 1988; 46(1):30-4. PubMed ID: 3389575
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein pattern and plasma lipoprotein lipase activities in patients with primary biliary cirrhosis. Relationship with increase of HDL2 fraction in Lp-X-positive and Lp-X-negative subjects.
Baldo-Enzi G; Baiocchi MR; Grotto M; Floreani AR; Zagolin M; Chiaramonte M; Cera F; Fellin R
Dig Dis Sci; 1988 Oct; 33(10):1201-7. PubMed ID: 3168690
[TBL] [Abstract][Full Text] [Related]
19. Lipids and progression of renal disease: role of modified low density lipoprotein and lipoprotein(a).
Wanner C; Greiber S; Krämer-Guth A; Heinloth A; Galle J
Kidney Int Suppl; 1997 Dec; 63():S102-6. PubMed ID: 9407434
[TBL] [Abstract][Full Text] [Related]
20. An in vivo evaluation in man of the transfer of esterified cholesterol between lipoproteins and into the liver and bile.
Schwartz CC; Vlahcevic ZR; Halloran LG; Swell L
Biochim Biophys Acta; 1981 Jan; 663(1):143-62. PubMed ID: 7011409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
